|
Volumn 20, Issue 6s, 2002, Pages BE36-BE39
|
In-licensing as a business model
|
Author keywords
[No Author keywords available]
|
Indexed keywords
DRUG PRODUCTS;
INDUSTRY;
BUSINESS MODEL;
BIOTECHNOLOGY;
BIOTECHNOLOGY;
CAPITAL;
COMMERCIAL PHENOMENA;
DRUG APPROVAL;
ECONOMICS;
FINANCE;
LICENSING;
PRIORITY JOURNAL;
REVIEW;
ARTICLE;
COOPERATION;
DRUG INDUSTRY;
LEGAL ASPECT;
NONBIOLOGICAL MODEL;
TECHNOLOGY;
UNITED STATES;
BIOTECHNOLOGY;
COMMERCE;
COOPERATIVE BEHAVIOR;
DRUG INDUSTRY;
ENTREPRENEURSHIP;
LICENSURE;
MODELS, ORGANIZATIONAL;
TECHNOLOGY TRANSFER;
UNITED STATES;
|
EID: 0036637574
PISSN: 10870156
EISSN: 15461696
Source Type: Journal
DOI: 10.1038/nbt0602supp-BE36 Document Type: Note |
Times cited : (7)
|
References (0)
|